Brief: Active Biotech Q2 Oper Loss Narrows To SEK 11.3 Mln

Active Biotech AB publ

24/08/2023 07:56

Aug 24 (Reuters) - Active Biotech AB publ  ACTI.ST :
    * ACTIVE BIOTECH INTERIM REPORT Q2 2023
    * Q2 OPERATING LOSS SEK 11.3 MILLION VERSUS LOSS SEK 14.0 MILLION YEAR AGO

Source text for Eikon:  ID:nMFN5YkPkM 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))